790 related articles for article (PubMed ID: 23817077)
1. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
2. Primary human tumor xenografted models ('tumorgrafts') for good management of patients with cancer.
Decaudin D
Anticancer Drugs; 2011 Oct; 22(9):827-41. PubMed ID: 21623183
[TBL] [Abstract][Full Text] [Related]
3. Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement.
Kumar S; Mokhtari RB; Yeger H; Baruchel S
Expert Opin Drug Discov; 2012 Nov; 7(11):1093-106. PubMed ID: 22998522
[TBL] [Abstract][Full Text] [Related]
4. Lessons from patient-derived xenografts for better in vitro modeling of human cancer.
Choi SY; Lin D; Gout PW; Collins CC; Xu Y; Wang Y
Adv Drug Deliv Rev; 2014 Dec; 79-80():222-37. PubMed ID: 25305336
[TBL] [Abstract][Full Text] [Related]
5. Animal models of human disease: challenges in enabling translation.
McGonigle P; Ruggeri B
Biochem Pharmacol; 2014 Jan; 87(1):162-71. PubMed ID: 23954708
[TBL] [Abstract][Full Text] [Related]
6. [Preclinical models in oncology].
Vrignaud P
Bull Cancer; 2011 Nov; 98(11):1355-61. PubMed ID: 22023796
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer models for novel drug discovery.
Golovko D; Kedrin D; Yilmaz ÖH; Roper J
Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
Merk J; Rolff J; Becker M; Leschber G; Fichtner I
Eur J Cardiothorac Surg; 2009 Sep; 36(3):454-9. PubMed ID: 19502076
[TBL] [Abstract][Full Text] [Related]
9. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
Prestwich GD
Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
[TBL] [Abstract][Full Text] [Related]
10. Animal models for modeling pancreatic cancer and novel drug discovery.
Bisht S; Feldmann G
Expert Opin Drug Discov; 2019 Feb; 14(2):127-142. PubMed ID: 30657339
[TBL] [Abstract][Full Text] [Related]
11. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
[TBL] [Abstract][Full Text] [Related]
12. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
LaBarbera DV; Reid BG; Yoo BH
Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
[TBL] [Abstract][Full Text] [Related]
13. Genetically engineered models have advantages over xenografts for preclinical studies.
Becher OJ; Holland EC
Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152
[TBL] [Abstract][Full Text] [Related]
14. Fit-for purpose use of mouse models to improve predictivity of cancer therapeutics evaluation.
Wartha K; Herting F; Hasmann M
Pharmacol Ther; 2014 Jun; 142(3):351-61. PubMed ID: 24412280
[TBL] [Abstract][Full Text] [Related]
15. Mouse tumour models to guide drug development and identify resistance mechanisms.
Das Thakur M; Pryer NK; Singh M
J Pathol; 2014 Jan; 232(2):103-11. PubMed ID: 24122209
[TBL] [Abstract][Full Text] [Related]
16. Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).
Winograd B; Boven E; Lobbezoo MW; Pinedo HM
In Vivo; 1987; 1(1):1-13. PubMed ID: 2979758
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived tumor xenograft models for melanoma drug discovery.
Harris AL; Joseph RW; Copland JA
Expert Opin Drug Discov; 2016 Sep; 11(9):895-906. PubMed ID: 27454070
[TBL] [Abstract][Full Text] [Related]
18. Models of metastasis in drug discovery.
Talmadge JE
Methods Mol Biol; 2010; 602():215-33. PubMed ID: 20012401
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived xenografts as tools in pharmaceutical development.
Izumchenko E; Meir J; Bedi A; Wysocki PT; Hoque MO; Sidransky D
Clin Pharmacol Ther; 2016 Jun; 99(6):612-21. PubMed ID: 26874468
[TBL] [Abstract][Full Text] [Related]
20. Drug discovery in prostate cancer mouse models.
Valkenburg KC; Pienta KJ
Expert Opin Drug Discov; 2015; 10(9):1011-24. PubMed ID: 26027638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
